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Evidence on sunscreen use and cutaneous squamous cell carcinoma (cSCC) risk is limited. Most studies have
not taken sun protection factor (SPF) into consideration and used nonusers of sunscreen as the reference group.
Nonusers are likely a priori at lower cSCC risk than users. No study has investigated the effect of high- versus low-
SPF sunscreens on cSCC, appropriately adjusting for time-varying confounding. Using data from the Norwegian
Women and Cancer Study (1991–2016), we investigated whether use of SPF ≥15 versus SPF <15 sunscreens
reduces cSCC risk. We used a marginal structural Cox proportional hazards model with inverse probability of
treatment and censoring weights to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). During
follow-up of 148,781 women (mean follow-up, 14.3 years), 653 women were diagnosed with cSCC. The effect
on cSCC risk of sunscreens with SPF ≥15 versus SPF <15 was close to the null when used at any latitudes
(HR = 1.02, 95% CI: 0.82, 1.27) and when used in lower-latitude settings (HR = 1.05, 95% CI: 0.84, 1.32). In
conclusion, we found no indication that sunscreens with SPF ≥15 reduced Norwegian women’s cSCC risk more
than sunscreens with SPF <15, suggesting that either there is no difference in their effects long-term or the
difference is diluted by incorrect application.
cohort study; cutaneous squamous cell carcinoma; inverse probability weighting; marginal structural model; sun
protection factor; sunscreen; ultraviolet exposure
Abbreviations: CI, confidence interval; cSCC, cutaneous squamous cell carcinoma; HR, hazard ratio; NOWAC, Norwegian
Women and Cancer; RCT, randomized controlled trial; SPF, sun protection factor; UVR, ultraviolet radiation.
Cutaneous squamous cell carcinoma (cSCC) is among the
most common cancer types worldwide (1). National Nor-
wegian cSCC data shows 24% increase in age-standardized
incidence rates from 2010–2014 to 2015–2019 (2). Cumu-
lative sun exposure is considered the main cSCC risk factor
(1, 3), and sun protection recommendations include seeking
shade, wearing protective clothing, and using sunscreens
with sun protection factor (SPF) ≥15 (4, 5).
Evidence from randomized controlled trials (RCTs) shows
that sunscreen use decreases the risk of actinic keratosis
(6, 7), a known precursor of cSCC (1). The relationship
between sunscreen use and cSCC risk has been investigated
in 6 case-control studies (8–13), 1 cohort study (14), and 1
RCT (15, 16). One of the case-control studies (12) found an
inverse association between cSCC risk and use of sunscreens
with SPF 15–30 at ages 15–25 years, and the opposite for
ages older than 25 years. The cohort study (14) and the
other case-control studies (8–11, 13) found imprecise and
inconsistent results. In the RCT, daily use of sunscreens with
SPF ≥15 (specifically SPF 16) reduced cSCC tumor inci-
dence during the trial period and primary cSCC incidence
during extended follow-up (15, 16). Modern sunscreens have
improved in performance compared with those used before
the 21st century, when half of these studies were conducted
(17, 18). Moreover, most of these studies did not take SPF
into consideration and regarded nonusers of sunscreen as
the reference group. Nonusers are likely a priori at lower
cSCC risk than sunscreen users due to less sun exposure
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and less sun-sensitive phenotypic characteristics (19, 20).
Furthermore, the majority of the studies were conducted
in low-latitude, high–ambient ultraviolet radiation (UVR)
settings where people experience mainly nonintentional sun
exposure (21, 22). Studies from northern Europe, with lower
ambient UVR and mainly intermittent and intentional sun
exposure (23), are lacking.
An RCT randomizing participants to use of sunscreens
with different SPFs would be ideal. Given enough follow-up
time, and participants continuing using the same sunscreen
throughout, a causal effect of higher-SPF versus low-SPF
sunscreens on cSCC risk could be estimated. Realization of
such an RCT is highly unlikely for ethical reasons (a control
arm cannot be denied regular use of higher-SPF sunscreen)
and the need long-term intervention and follow-up. Cohort
studies are less constraining, and typically have long follow-
up. However, they are still prone to bias arising from unmea-
sured confounding, informative censoring, and time-varying
confounding (24, 25). Marginal structural models, popular
in causal inference, can help with some of these issues and
estimate causal effects from observational data with time-
varying confounders (25–29).
In spite of the limited evidence on sunscreen use and
cSCC, and because of the lack of studies with repeated infor-
mation on sunscreen use and confounders, no observational
study has yet used marginal structural models to investigate
the causal effect of higher-SPF versus low-SPF sunscreens
on cSCC risk. The population-based Norwegian Women and
Cancer (NOWAC) cohort study holds unique information on
host factors, sunscreen use, and history of sunburns and sun
exposure, with up to 3 repeated measurements (19). Thus,
based on NOWAC, we aimed to use marginal structural mod-
els to prospectively investigate whether use of sunscreens
with SPF ≥15 versus SPF <15 reduces cSCC risk. We also
applied standard methods for comparison.
METHODS
The NOWAC cohort study
The NOWAC cohort study has been described in detail
elsewhere (19, 30). Briefly, women were selected randomly
from the Norwegian Population Register and issued a
questionnaire at study inclusion in 1991–2007. In total,
172,472 women, aged 31–70 years at inclusion, partic-
ipated (response rate, 54%). First and second follow-up
questionnaires were issued approximately every 5 years
(response rates 80% and 79%, respectively). Participants of
the NOWAC cohort study have all signed broad informed
consent to study risk factors and cancer, and the cohort has
been approved by the national Data Protection Authority
and the Regional Committees for Medical Health Research
Ethics of North Norway. Data were handled according to
the permission given by the Data Protection Authority. This
project received anonymous data only.
Sunscreen use
Participants were asked to report whether they used sun-
screen within Norway or other northern places (hereafter
high latitudes) and/or on sunbathing vacations in lower lat-
itudes (typically southern European countries with latitudes
of <45◦, e.g., Spain or Greece) at the time of filling in
the questionnaires. If sunscreen was used, participants were
asked to report the SPF (19). Participants were classified as
nonusers if they did not indicate sunscreen use or answered
0 to the SPF question. Users were classified as using sun-
screens with SPF <15 or ≥15 based on the minimally
recommended SPF level (4) considered sufficient to prevent
sunburn if properly applied (31). We created a variable for
sunscreen use in high- and lower-latitude settings combined
(for high/lower: none/none, SPF <15/none or none/SPF
<15, SPF <15/SPF <15, SPF ≥15 in at least 1 setting),
and in high- and lower-latitude settings separately (none,
SPF <15, SPF ≥15) (19). We used use of sunscreen with
SPF <15/SPF <15 as the referent in high-/lower-latitude
settings, and a referent of SPF <15 in high- and lower-
latitude settings separately (19). Sunscreen use was assumed
to be representative of the current use, as one would in an
RCT (with intention-to-treat analysis).
Time-fixed covariates
Residential ambient UVR exposure was categorized
based on mean ambient UVR hours of the region of resi-
dence (32) (latitudes 70◦–58◦) as low (northern Norway),
medium-low (central Norway), medium (southwestern
Norway), and highest (southeastern Norway) (33, 34).
Participants reported education (in years: ≤10, 11–13, ≥14),
smoking (never, former, current), hair color (black/dark
brown, brown, blond/yellow, red), untanned skin color (color
scale from 1 (very fair) to 10 (very dark); categorized as light
(grades 1–3), medium (grades 4–5), dark (grades 6–8), very
dark (grades 9–10)), and freckling when sunbathing (no,
yes). Skin reactions to acute and chronic sun exposure were
recorded for a subsample of the cohort.
Time-varying covariates
Annual number of sunburns that resulted in pain, blister-
ing, and subsequent peeling (never, 1, 2–3, 4–5, ≥6), annual
number of weeks spent on sunbathing vacations in high
and/or lower latitudes (never, 1, 2–3, 4–6, ≥7), and history of
use of indoor tanning devices (never, rarely, 1, 2, 3–4 times/
month, >1 time/week) were recorded at study inclusion
for childhood (<10 years), adolescence (10–19 years), and
adulthood, and updated in follow-up questionnaires. Cumu-
lative number of sunburns was calculated by converting
reported frequencies for all age periods to a yearly amount
and multiplying this by the number of years for the given
period (33, 34). The cumulative number was categorized
as none, lowest (1–30 sunburns), middle (31–53 sunburns),
or highest (>53 sunburns) tertile. Cumulative number of
weeks on sunbathing vacations was calculated similarly:
never, lowest (1–73 weeks), middle (74–138 weeks), or
highest (>138 weeks) tertile (33, 34). In the analyses, we
further collapsed none/never with the lowest tertile of cumu-
lative numbers of sunburns/sunbathing vacations due to low
numbers of participants in those categories. Use of indoor
tanning devices was categorized as never/ever.
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Reproducibility of the NOWAC questionnaire was good
(κ/intraclass correlation coefficient, 0.49–0.77) and indepen-
dent of age, education, and skin color (35).
Follow-up
The cohort was linked to the Cancer Registry of Norway
using the unique personal identification number of Norwe-
gian residents for follow-up of cancer incidence and vital
status (alive, emigrated, or dead) until December 31, 2016.
cSCC cases were identified by the International Classifi-
cation of Diseases, Seventh Revision, codes 191.0–191.9,
including the International Classification of Diseases for
Oncology, Third Edition, morphology codes 80703, 80713,
80763, 80953, 80513, 80723, and 80743. We excluded cases
with code 191.4 (perineum, perianal) because they are unre-
lated to UVR exposure. The Cancer Registry of Norway
does not routinely record information on basal cell carci-
noma.
Study sample
Of the 172,472 women who returned questionnaires, a
total of 150,073 received questions about sunscreen use
either at study inclusion or in the first follow-up question-
naire (Figure 1). We excluded women with very dark skin
(n = 290) and women diagnosed with cSCC (n = 114)
or cutaneous melanoma (n = 865) before answering the
sunscreen questions. We further excluded 23 women who
emigrated or died before the date of the questionnaire return,
resulting in 148,781 women, born 1927–1957.
Statistical analysis
The effect of sunscreen use on cSCC was estimated using
a marginal structural Cox proportional hazards model,
with hazard ratios (HRs) estimated using stabilized inverse
probability of treatment and censoring weighting. Under
assumptions of exchangeability, positivity, and consistency,
weighting would mimic an RCT in which participants are
randomized to sunscreen use with different SPFs and where
censoring is random, allowing estimation of a causal effect
also when exposure and confounders are time-varying (25–
27, 36). The method has been described elsewhere (26,
36). For inverse probability of treatment weights, we used
multinomial logistic regression (37) to estimate, at each
time point, each participant’s probability of the observed
level of sunscreen used, given their covariates. Similarly, for
inverse probability of censoring weights, we used pooled
logistic regression to estimate each participant’s probability
of not being censored. (For details on weights estimation, see
Web Appendix 1, available at https://doi.org/10.1093/aje/
kwab216.) Covariates included in the models were based
on assumptions in directed acyclic graphs (38, 39) (Web
Figure 1A–B). Time-fixed covariates (recorded once in the
first sunscreen questionnaire) included: age at return of the
first sunscreen questionnaire, calendar year at recruitment to
NOWAC (1991–1992, 1996–1997, 2003–2008), residential
ambient UVR exposure, smoking status, hair color, and
freckling when sunbathing. Sunscreen use and cumulative
numbers of sunburns and sunbathing vacations were includ-
ed as time-fixed (using only information recorded in the first
sunscreen questionnaire) and as time-varying (using updated
information from follow-up questionnaires) to assess the
influence of time-varying confounding. Unweighted models
were fitted (Cox regression, same covariates) to assess how
weighting affected the results.
Analyses were conducted for sunscreen use in combined
high-/lower-latitude settings, as well as high- and lower-
latitude settings separately. The latter analyses were con-
ducted in the subsample of women who spent at least 1
week of sunbathing vacation in lower latitudes. Participants
contributed person-years of follow-up from receipt of the
first sunscreen questionnaire (hereafter baseline) to first
primary cSCC diagnosis, melanoma diagnosis (i.e., censor-
ing at melanoma diagnosis), emigration, death, or end of
follow-up (December 31, 2016), whichever occurred first.
We used time-on-study as time scale, and we used robust
variances to compute 95% confidence intervals (CIs) (40).
All models (except marginal structural models with time-
fixed covariates) were stratified by calendar year at inclu-
sion. A likelihood ratio test was used to test for interaction
between sunscreen use and cumulative number of sunburns
(19).
In the study sample (n = 148,781), we had information on
sunscreen use in 88% of women (n = 131,303, Figure 1),
with up to 30% missing when combining covariates. To
address this, we used multiple imputation with chained
equations (41) to impute 40 data sets. In each data set, we
conducted analyses using the models described above, and
estimates were pooled using Rubin’s rule (42).
We conducted several complete-case sensitivity analyses.
To investigate potential selection bias, we conducted analy-
ses not excluding prevalent melanomas and cSCCs. To eval-
uate the assumption on the direction of the causal pathway
between sunscreen use and sunburns, we conducted analyses
based on directed acyclic graphs where the direction of
this pathway was reversed (Web Figure 2A–B). To assess
whether model choice affected the results, we also fitted
a marginal structural Aalen additive hazards model (only
high-/lower-latitude settings) (43). (For details on these and
additional sensitivity analyses, see Web Appendix 2.) Sta-
tistical analyses were conducted using R, version 3.6.1 (R
Foundation for Statistical Computing, Vienna, Austria).
RESULTS
Mean age at baseline for the 148,781 women included
was 53.2 (standard deviation, 6.5) years. Mean follow-up
was 14.3 (standard deviation, 3.8) years, during which 653
women were diagnosed with incident primary cSCC. This
was the first diagnosis of any cancer for 519 women, second
for 110, and the third to fifth cancer diagnosis for 24 women.
Mean age at cSCC diagnosis was 68.3 years and similar
among women with cSCC as their first (67.5 years) and
second (68.1 years) cancer diagnosis, but slightly higher
for women with cSCC as their third to fifth (70.7 years)
cancer diagnosis. Head (n = 280) was the most common site,
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Figure 1. Selection of participants from enrollment into the study sample, Norwegian Women and Cancer Study, 1991–2016. cSCC, cutaneous
squamous cell carcinoma.
followed by trunk (includes neck, shoulders, and hips, n =
151) (Web Table 1).
Among the 131,303 who answered the sunscreen ques-
tions, a total of 111,159 (85%) reported using sunscreen
(of any SPF) in high- and/or lower-latitude settings at the
time of the first sunscreen questionnaire (Table 1). Users
were younger than nonusers, and SPF ≥15 sunscreens were
more common in women recruited in 2003–2008, living
in areas with higher ambient UVR, with higher education,
lighter hair and skin color, freckling when sunbathing, more
sensitive skin, higher cumulative numbers of sunburns and
sunbathing vacations, never/former smokers, and in women
using indoor tanning.
In weighted analyses with multiple imputation and time-
varying covariates (Table 2), the estimate of the causal
effect on cSCC risk was close to the null in high-/lower-
latitude settings for SPF ≥15 in at least 1 setting versus
SPF <15/SPF <15 (HR = 1.02, 95% CI: 0.82, 1.27) and in
lower-latitude settings for SPF ≥15 versus SPF <15 (HR =
1.05, 95% CI: 0.84, 1.32). There was higher cSCC risk in
high-latitude settings for SPF ≥15 versus SPF <15 (HR =
1.33, 95% CI: 1.05, 1.67), although it was closer to the
null in the complete-case analysis (HR = 1.16, 95% CI:
0.85, 1.58). Nonusers had lower cSCC risk in high-/lower-
latitude settings compared with users of SPF <15/SPF <15
(HR = 0.71, 95% CI: 0.54, 0.94) (Table 2). Similar results
were found in time-fixed models (Table 2). Confidence
intervals included the null in all complete-case analyses.
No indication of interaction was found between sunscreen
use and cumulative number of sunburns (0.35 ≤ P for
interaction ≤ 0.94).
Sensitivity analyses where prevalent melanomas and
cSCCs were included (Web Table 2), those based on directed
acyclic graphs where the direction of the causal pathway
between sunscreen use and sunburns was reversed (Web
Table 3), and those using the marginal structural Aalen
additive hazards model (Web Figure 3) showed similar
results. None of the sensitivity analyses described in Web
Appendix 2 produced meaningful differences.
DISCUSSION
In this large, prospective study, we found no indication
that SPF ≥15 sunscreens reduced cSCC risk more than SPF
<15 sunscreens in high-/lower-latitude settings or lower-
latitude settings. For sunscreen use in high-latitude settings,
increased risk was found for SPF ≥15 versus SPF <15 in the
multiple imputation analysis, although the effect was closer
to the null in the complete-case analysis.
We conducted several sensitivity analyses to assess the
impact of modeling choices on the estimates. Results
were similar in models with time-fixed and time-varying
covariates, as well as in the unweighted models, suggesting
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Table 1. Characteristics of Participants in a Study of Sunscreen Use and Cutaneous Squamous Cell Carcinoma Risk, Stratified by Sunscreen
Use (n = 131,303), Norwegian Women and Cancer Study, 1991–2016




SPF <15/None SPF <15/SPF <15
SPF ≥15 in at
Least 1 Setting
No. %b No. %b No. %b No. %b
Participants 20,144 15.3 32,267 24.6 43,175 32.9 35,717 27.2
Total person-years of follow-up 289,081 489,274 630,759 472,620
Person-years of follow-upc 14.4 (4.0) 15.2 (3.7) 14.6 (3.7) 13.2 (3.5)
Age at answering first sunscreen
questions, yearsc
55.6 (7.5) 52.2 (6.5) 52.3 (5.9) 53.1 (5.7)
Incident cSCC cases 87 15.6 122 21.8 204 36.5 146 26.1
Age at diagnosis, yearsc 71.8 (8.6) 69.1 (8.9) 66.7 (8.2) 65.4 (8.7)
Year at recruitment 131,303
1991–1992 5,474 13.1 13,584 32.5 15,207 36.4 7,523 18.0
1996–1997 7,079 25.9 7,288 26.6 8,085 29.5 4,924 18.0
2003–2008 7,591 12.2 11,395 18.3 19,883 32.0 23,270 37.4
Residential ambient UVR exposure 131,303
Low (northern Norway) 6,191 21.7 7,130 24.9 7,262 25.4 8,009 28.0
Medium-low (central Norway) 2,132 15.1 3,854 27.2 4,883 34.5 3,275 23.2
Medium (southwestern Norway) 2,971 12.0 5,986 24.2 8,471 34.3 7,273 29.4
Highest (southeastern Norway) 8,850 13.9 15,297 24.0 22,559 35.3 17,160 26.9
Education, years 124,561
≤10 10,180 24.4 11,287 27.1 11,546 27.7 8,637 20.7
11–13 4,178 11.2 9,362 25.1 13,691 36.7 10,060 27.0
≥14 4,019 8.8 10,245 22.5 16,091 35.3 15,265 33.5
Smoking status at baseline 125,503
Never 6,974 15.8 11,333 25.6 13,463 30.5 12,434 28.1
Former 5,532 11.9 10,256 22.0 16,394 35.2 14,389 30.9
Current 6,439 18.5 9,116 26.2 11,435 32.9 7,738 22.3
Hair color 127,360
Black/dark brown 4,311 19.8 5,558 25.5 6,798 31.2 5,130 23.5
Brown 7,413 14.3 12,934 24.9 17,666 34.1 13,858 26.7
Blond/yellow, red 7,309 13.6 12,756 23.8 17,620 32.8 16,007 29.8
Untanned skin color 120,376
Dark 3,594 13.8 6,537 25.0 9,908 38.0 6,068 23.2
Medium 5,639 12.3 11,503 25.2 16,350 35.8 12,212 26.7
Light 7,338 15.1 11,758 24.2 14,299 29.4 15,170 31.2
Freckling when sunbathing 124,227
No 13,103 16.2 20,172 25.0 27,134 33.6 20,406 25.3
Yes 4,737 10.9 10,424 24.0 14,239 32.8 14,012 32.3
Skin reaction to acute sun
exposured
65,833
Brown 3,710 20.2 5,290 28.7 6,908 37.5 2,495 13.6
Red 5,091 15.5 10,170 30.9 11,673 35.5 5,965 18.1
Red with pain 1,750 15.1 3,881 33.4 3,360 29.0 2,613 22.5
Red with pain and blisters 475 16.2 895 30.6 668 22.8 889 30.4
Table continues
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Table 1. Continued




SPF <15/None SPF <15/SPF <15
SPF ≥15 in at
Least 1 Setting
No. %b No. %b No. %b No. %b
Skin reaction to chronic sun
exposured
64,793
Deep brown 1,573 16.4 2,827 29.4 3,872 40.3 1,328 13.8
Brown 5,753 15.5 11,462 30.8 13,725 36.9 6,285 16.9
Light brown 3,070 18.3 5,327 31.7 4,545 27.1 3,853 22.9
Never brown 487 41.5 267 22.8 106 9.0 313 26.7
Cumulative no. of sunburns 104,829
None 3,502 27.5 3,127 24.5 3,580 28.1 2,544 19.9
Lowest tertile 4,233 13.1 8,163 25.2 10,954 33.8 9,084 28.0
Middle tertile 3,232 10.8 8,050 27.0 10,657 35.7 7,897 26.5
Highest tertile 2,666 8.9 6,672 22.4 10,474 35.1 9,994 33.5
Cumulative no. of weeks on
sunbathing vacations
112,998
None 3,729 57.1 1,816 27.8 164 2.5 818 12.5
Lowest tertile 5,772 16.5 11,230 32.1 10,068 28.8 7,924 22.6
Middle tertile 3,081 8.6 8,779 24.6 12,702 35.6 11,102 31.1
Highest tertile 2,502 7.0 6,082 17.0 15,149 42.3 12,080 33.7
Indoor tanning 113,032
Never 7,836 22.9 9,845 28.8 7,091 20.8 9,377 27.5
Ever 7,090 9.0 18,024 22.8 31,261 39.6 22,508 28.5
Abbreviations: cSCC, cutaneous squamous cell carcinoma; SPF, sun protection factor; UVR, ultraviolet radiation.
a Sunscreen use in high-/lower-latitude settings = sunscreen use in high- and lower-latitude settings combined.
b Percentages are row percentages. Because of rounding, percentages may not sum up to 100.
c Values are expressed as mean (standard deviation).
d Recorded in subsamples of the cohort.
minimal time-varying confounding. Only 2.8% of women
had information from 3 time points, which may explain these
results. We found similar results in the marginal structural
Aalen additive hazards model, indicating robustness of the
estimates. Prevalent melanomas and cSCCs were excluded
because of potential recall bias and bias due to changes
in sun-protection behavior before the sunscreen questions
were answered. Further, studies have found that skin cancer
survivors have higher subsequent skin cancer risk than the
general population (44, 45). However, our results were also
similar in analyses not excluding prevalent melanomas and
cSCCs.
NOWAC is a well-characterized cohort of women with
complete follow-up and information about sunburns and
sunbathing vacations from all decades of life. NOWAC is
representative of Norwegian women aged 45–74 years with
regard to total cancer incidence (30), with no major selection
bias (46), and with almost no selection of participants from
the recruitment questionnaire to the first follow-up question-
naire (30). Furthermore, 99.7% of cSCCs are morphologi-
cally verified (2), and all information was collected prior to
cancer diagnosis, limiting the potential for recall bias. Expo-
sure misclassification, inevitable in epidemiologic studies, is
likely nondifferential in cohort studies, although differential
misclassification can occur when forming categories (47).
To our knowledge, no other study on sunscreen use and
cSCC used information collected during follow-up, or com-
pared users of higher-SPF sunscreens with users of low-SPF
sunscreens. The one RCT found a protective effect of daily
sunscreen use on cSCC incidence, versus discretionary use
of sunscreens (15, 16). However, this study was conducted
in Australia, where UVR is much higher and sun exposure
is likely nonintentional (21, 22), and the control group
included nonusers of sunscreen.
The differences between multiple imputation analyses
and complete-case analyses in high-/lower-latitude settings
and high-latitude settings may indicate that some data were
missing not at random (42). Moreover, a substantial amount
of data were imputed (up to 22% for individual covariates),
which could have influenced the results. Furthermore, in
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Table 2. Hazard Ratios for Sunscreen Use and Risk of Cutaneous Squamous Cell Carcinoma Among Participants in the Norwegian Women
and Cancer Study, 1991–2016




















HR 95% CI HR 95% CI HR 95% CI HR 95% CI





None/none 11,612 12.3 35 0.72 0.46, 1.11 0.73 0.49, 1.08 0.71 0.53, 0.95 0.71 0.55, 0.92
None/SPF <15, SPF
<15/none
23,109 24.4 68 0.77 0.56, 1.05 0.79 0.58, 1.06 0.79 0.62, 1.01 0.81 0.65, 1.00
SPF <15/SPF <15 32,165 34.0 123 1.00 Referent 1.00 Referent 1.00 Referent 1.00 Referent
SPF ≥15 in at least 1
setting
27,708 29.3 86 0.82 0.60, 1.11 0.95 0.72, 1.26 0.87 0.68, 1.13 0.97 0.78, 1.20
Time-varyingf
None/none 11,478 12.1 35 0.70 0.45, 1.07 0.73 0.49, 1.09 0.71 0.54, 0.94 0.76 0.58, 0.98
None/SPF <15, SPF
<15/none
19,408 20.5 64 0.82 0.60, 1.13 0.86 0.63, 1.17 0.85 0.66, 1.08 0.86 0.68, 1.09
SPF <15/SPF <15 30,137 31.9 113 1.00 Referent 1.00 Referent 1.00 Referent 1.00 Referent
SPF ≥15 in at least 1
setting
33,571 35.5 100 0.91 0.69, 1.20 0.96 0.73, 1.26 1.02 0.82, 1.27 1.04 0.85, 1.28





None 20,689 21.4 64 0.96 0.71, 1.30 0.91 0.68, 1.21 0.90 0.72, 1.11 0.85 0.69, 1.05
SPF <15 62,420 64.4 203 1.00 Referent 1.00 Referent 1.00 Referent 1.00 Referent
SPF ≥15 13,744 14.2 50 1.09 0.77, 1.55 1.29 0.94, 1.76 1.16 0.88, 1.54 1.26 0.99, 1.59
Time-varyingf
None 21,278 22.0 67 0.91 0.67, 1.23 0.88 0.66, 1.18 0.88 0.72, 1.09 0.86 0.70, 1.06
SPF <15 58,877 60.8 197 1.00 Referent 1.00 Referent 1.00 Referent 1.00 Referent
SPF ≥15 16,698 17.2 53 1.16 0.85, 1.58 1.13 0.83, 1.53 1.33 1.05, 1.67 1.28 1.03, 1.60
Table continues
high-latitude settings, we do not know on what occasions
the sunscreen was used, as opposed to lower-latitude settings
where participants were asked about sunscreen use on sun-
bathing vacations specifically.
A causal interpretation of our results is relying on a
number of assumptions not guaranteed in observational stud-
ies. We assumed that sunscreen use was a well-defined
exposure, similar to an RCT. We did not have information
on how/when participants applied sunscreen, so that within
one category of sunscreen use, sunscreen exposure may
be quite different. In addition, by design, only current use
was recorded. Exposure was updated during follow-up, but
we had no information on lifetime sunscreen use in the
past, including in childhood and adolescence, nor did we
have information on the number of hours spent outside,
or on other sun protective behavior such as avoiding the
sun or wearing protective clothing. Further, it has been
suggested that sunscreen use may be connected to extended
sun exposure, especially in regions with mainly intentional
sun exposure, such as Norway (21–23). Cohort studies such
as ours are prone to unmeasured/residual confounding.
Sensitivity analyses with different adjustment strategies
yielded similar results. Regarding nonusers, this group of
women was previously reported to be more likely to have
a less sun-sensitive phototype, live in areas of low ambient
UVR, and to report no sunburns, sunbathing vacations,
and use of indoor tanning devices (19). Thus, nonusers of
sunscreen were a priori at lower cSCC risk than users.
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Table 2. Continued




















HR 95% CI HR 95% CI HR 95% CI HR 95% CI





None 7,379 11.5 29 0.99 0.65, 1.53 1.01 0.67, 1.51 0.85 0.62, 1.17 0.87 0.64, 1.17
SPF <15 36,334 56.6 138 1.00 Referent 1.00 Referent 1.00 Referent 1.00 Referent
SPF ≥15 20,492 31.9 68 0.97 0.71, 1.33 1.05 0.78, 1.41 0.96 0.74, 1.23 0.99 0.78, 1.25
Time-varyingf
None 7,452 11.6 33 1.08 0.72, 1.63 1.10 0.75, 1.63 0.99 0.73, 1.35 0.99 0.74, 1.33
SPF <15 32,555 50.7 126 1.00 Referent 1.00 Referent 1.00 Referent 1.00 Referent
SPF ≥15 24,198 37.7 76 0.98 0.74, 1.31 1.01 0.76, 1.35 1.05 0.84, 1.32 1.06 0.85, 1.33
Abbreviations: CI, confidence interval; HR, hazard ratio; SPF, sun protection factor.
a Analyses with multiple imputation of missing data conducted using chained equations and a total of 40 imputed data sets, using the same
models as in the complete-case analyses (n = 148,781; 653 cases).
b In the model with time-varying covariates, the numbers correspond to the category in which participants were at the end of follow-up.
c Marginal structural Cox proportional hazards model estimated using stabilized inverse probability of treatment weights and stabilized inverse
probability of censoring weights. Weights were constructed using calendar year at study inclusion, age at baseline, residential ambient ultraviolet
radiation exposure, smoking status, hair color, freckling when sunbathing, and cumulative numbers of sunburns and sunbathing vacations. In
the models with time-varying covariates, time-fixed covariates were also included in the numerator of the weights and in the marginal structural
model to further stabilize the weights.
d Unweighted Cox proportional hazards model, adjusted for age at baseline, residential ambient ultraviolet radiation exposure, smoking
status, hair color, freckling when sunbathing, and cumulative numbers of sunburns and sunbathing vacations, stratified by calendar year at
study inclusion.
e Using only information recorded at baseline.
f Sunscreen use as well as cumulative numbers of sunburns and sunbathing vacations as time-varying covariates.
g Analyses were conducted in a subsample of women who spent at least 1 week of sunbathing vacation in lower latitudes (n = 94,408; 435
cases).
The effectiveness of sunscreen depends not only on its
SPF rating but also ultraviolet spectral absorption, amount
applied, reapplication, duration of sun exposure, and cover-
age of sun-exposed parts. It has been reported that people
use one-fifth to one-half of the recommended amount and
do not reapply as recommended (21, 48), resulting in mis-
classification of sunscreen use in the direction of lower SPF
(49). Participants in our reference group (SPF <15) were
sunscreen users, thereby already screening a certain amount
UVR and likely at lower risk for cSCC than nonusers. Thus,
any difference in effect may have been attenuated. Finally,
cumulative sun exposure is the main cSCC risk factor (1, 3).
Although sunscreens are designed to protect against UVR,
some radiation will always penetrate the skin (e.g., 10% for
SPF 10, 6.3% for SPF 15, and 3.3% for SPF 30, with correct
application) (50). This will be cumulative over time, poten-
tially rendering any difference in effect between sunscreens
marginal.
To our knowledge, this prospective study is the first to
try to investigate the causal effect of use of sunscreens
of different SPFs on cSCC risk. We found no indication
that sunscreens with SPF ≥15 reduced Norwegian women’s
cSCC risk more than sunscreens with SPF <15, suggesting
that either there is no difference in their effect long term,
or the difference is diluted by incorrect application. The
importance of correct sunscreen application should therefore
be emphasized.
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